Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Linda S. Brady, Sarah H. Lisanby & Joshua A. Gordon. (2023) New directions in psychiatric drug development: promising therapeutics in the pipeline. Expert Opinion on Drug Discovery 18:8, pages 835-850.
Read now
Read now
Articles from other publishers (18)
Steven M. Paul & William Z. Potter. (2023) Finding new and better treatments for psychiatric disorders. Neuropsychopharmacology 49:1, pages 3-9.
Crossref
Crossref
Allison Feduccia, Gabby Agin-Liebes, Collin M. Price, Nicole Grinsell, Summer Paradise & David M. Rabin. (2023) The need for establishing best practices and gold standards in psychedelic medicine. Journal of Affective Disorders 332, pages 47-54.
Crossref
Crossref
M. Lynn Crismon, Janet Walkow & Roger W. Sommi. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry
131
167
.
Owen Carmichael. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry
299
333
.
Valentin K. Gribkoff & Leonard K. Kaczmarek. 2023. Drug Development in Psychiatry. Drug Development in Psychiatry
255
285
.
William Z. Potter. (2022) Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms. Journal of Clinical Psychopharmacology 42:6, pages 523-525.
Crossref
Crossref
Jose Carlos Appolinario & Antonio Egidio Nardi. (2022) The use of ketamine and esketamine in psychiatry: now and beyond. Jornal Brasileiro de Psiquiatria 71:3, pages 164-165.
Crossref
Crossref
Piotr Ozieranski, Janos Gyorgy Pitter, Emily Rickard, Shai Mulinari & Marcell Csanadi. (2021) A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness 44:1, pages 188-210.
Crossref
Crossref
Dean Mobbs, Toby Wise, Nanthia Suthana, Noah Guzmán, Nikolaus Kriegeskorte & Joel Z. Leibo. (2021) Promises and challenges of human computational ethology. Neuron 109:14, pages 2224-2238.
Crossref
Crossref
Alexander V. Sapegin, Anatoly A. Peshkov, Evgeny V. Kanov, Raul R. Gainetdinov, Beata Duszyńska, Andrzej J. Bojarski & Mikhail Krasavin. (2021) Novel medium-sized di(het)areno-fused 1,4,7-(oxa)thiadiazecines as probes for aminergic receptors. Mendeleev Communications 31:4, pages 501-503.
Crossref
Crossref
Ekaterina Levashova, Andrey Firsov, Olga Bakulina, Anatoly Peshkov, Evgeny Kanov, Raul R. Gainetdinov & Mikhail Krasavin. (2021) Rare cis-configured 2,4-disubstituted 1-alkylpiperidines: synthesized and tested against trace-amine-associated receptor 1 (TAAR1). Mendeleev Communications 31:4, pages 488-489.
Crossref
Crossref
Mark David Tricklebank, Trevor W. Robbins, Camilla Simmons & Erik H. F. Wong. (2021) Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology. Psychopharmacology 238:6, pages 1417-1436.
Crossref
Crossref
Brenda WJH Penninx, Daniel S Pine, Emily A Holmes & Andreas Reif. (2021) Anxiety disorders. The Lancet 397:10277, pages 914-927.
Crossref
Crossref
Emily Dudek & David Dodell-Feder. (2021) The efficacy of real-time functional magnetic resonance imaging neurofeedback for psychiatric illness: A meta-analysis of brain and behavioral outcomes. Neuroscience & Biobehavioral Reviews 121, pages 291-306.
Crossref
Crossref
Nikolaos Koutsouleris, Dominic B. Dwyer, Franziska Degenhardt, Carlo Maj, Maria Fernanda Urquijo-Castro, Rachele Sanfelici, David Popovic, Oemer Oeztuerk, Shalaila S. Haas, Johanna Weiske, Anne Ruef, Lana Kambeitz-Ilankovic, Linda A. Antonucci, Susanne Neufang, Christian Schmidt-Kraepelin, Stephan Ruhrmann, Nora Penzel, Joseph Kambeitz, Theresa K. Haidl, Marlene Rosen, Katharine Chisholm, Anita Riecher-Rössler, Laura Egloff, André Schmidt, Christina Andreou, Jarmo Hietala, Timo Schirmer, Georg Romer, Petra Walger, Maurizia Franscini, Nina Traber-Walker, Benno G. Schimmelmann, Rahel Flückiger, Chantal Michel, Wulf Rössler, Oleg Borisov, Peter M. Krawitz, Karsten Heekeren, Roman Buechler, Christos Pantelis, Peter Falkai, Raimo K. R. Salokangas, Rebekka Lencer, Alessandro Bertolino, Stefan Borgwardt, Markus Noethen, Paolo Brambilla, Stephen J. Wood, Rachel Upthegrove, Frauke Schultze-Lutter, Anastasia Theodoridou & Eva Meisenzahl. (2021) Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression. JAMA Psychiatry 78:2, pages 195.
Crossref
Crossref
Michelle A. Worthington, Elaine F. Walker, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Barbara A. Cornblatt, Daniel H. Mathalon, Thomas H. McGlashan, Diana O. Perkins, Larry J. Seidman, Ming T. Tsuang, Scott W. Woods & Tyrone D. Cannon. (2021) Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophrenia Research 227, pages 95-100.
Crossref
Crossref
Michele Fornaro, Domenico De Berardis, Annalisa Anastasia & Andrea Fusco. 2021. Major Depressive Disorder. Major Depressive Disorder
449
461
.
Nathaniel Z. Counts, Paul Gionfriddo & Richard H. Chapman. (2020) Modeling Medicaid and Medicare Savings from Reduced Poverty and Disability to Promote Investment in Mental Health and Substance Use Interventions in the USA. Applied Health Economics and Health Policy 18:5, pages 601-604.
Crossref
Crossref